McNeil May See Criminal Penalties Over Recall

摘要

The FDA may pursue criminal penalties against McNeil Consumer Healthcare, the Johnson & Johnson (J&J) subsidiary responsible for a massive recall of OTC children's drugs, including infant Tylenol.rnTestifying at a House Committee on Oversight and Government Reform hearing Thursday, CDER Office of Compliance Director Deborah Autor said the situation has been referred to the FDA's criminal investigation unit.rnThe agency also is considering other enforcement actions that may include seizure and injunction as a result of an ongoing pattern of good manufacturing practice issues at McNeil's Fort Washington, Pa., facility, she said.